 |
|
 |
About Cipla Limited
Established in 1935, Cipla stands for The Chemical, Industrial, Pharmaceutical Laboratories. Head Office is based in Mumbai, with plants based in Bangalore, Vikhroli, Patalganga, Kurkumbh, Goa, Baddhi.
Cipla is currently India’s second largest pharmaceutical Company in terms of sales and it produces a range of low-cost pharmaceutical ingredients (APIs), prescription drugs, OTC products, and formulations. Exports constitute approximately 50% of its sales and it markets products in more than 170 countries. Formulations accounted for 73% of Cipla’s exports in 2006 and APIs accounted for the remaining 27%.
For more information on Cipla log on http://www.cipla.com
|
|
About the GMP Audit
The audit on Cipla Patalganga Unit 1 site was performed on 5 - 6 September 2006 and Cipla Patalganga Unit 2 site was performed on the 26 - 27 June 2007. The Report has combined the two sites and includes photographs and is 61 pages long, excluding appendices. Including appendices the Report is 179 pages long.
The Audit Report provides information on the site facilities and covers the materials Danazol USP, Escitalopram Oxalate, Finasteride, Sumatriptan Succinate, Valaciclovir Hydrochloride, Cetirizine Dihydrochloride, Doxazosin Mesylate, Fluconazole, Praziquantel, Salbutamol Sulphate, Terbutaline Sulphate, Alfuzosin Hydrochloride, Desloratadine, Perindopril Erbumine Monohydrate, Finasteride (BSA), Levo Salbutamol Hydrochloride, Lorazepam, Rivastigmine Hydrogen Tartrate, Salmeterol Xinafoate, Tamsulosin HCL, Tolterodine Tartrate, along with a comprehensive review of their quality systems.
|
|
How to Purchase an Audit
There are just two steps to purchasing a conducted PharmAssess Audit Report:
- A Quotation will be sent to you, followed by a Service Agreement, on request, for the purchase of an Audit Report.
- Once we receive approval of the Quotation we will dispatch the Audit Report, accompanied by an Invoice.
Please note that if there are other audits that you are interested in, which are not noted in our GMP Audit Section of this website, please contact us to discuss your audit requirements, which we can arrange on your behalf.
Contact Us
If you require further information about the PharmAssess services offered by Rephine, or you would like to purchase an Audit Report today, please
contact us by email at
enquiries@rephine.com or telephone us on +44 (0)1763 853135.
|
|
